---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-036026"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:42:06.354196+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech to announce Q2 2024 results on August 13, 2024

## Summary
- Company will report Q2 2024 financial results and provide business update before market open on August 13, 2024.
- Press release will be available on the Investor Relations section of PDS Biotech's website.
- No financial figures, guidance changes, or material updates included in this pre-announcement.

## SEC filing metadata
- accession: 0001140361-24-036026
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036124036026/0001140361-24-036026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036124036026/ef20033709_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-036026
- JSON: https://secwatch.observer/filing/0001140361-24-036026.json
- Plain text: https://secwatch.observer/filing/0001140361-24-036026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.